BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35700577)

  • 1. Autophagy and cellular senescence in classical Hodgkin lymphoma.
    Kyriazopoulou L; Karpathiou G; Hatzimichael E; Peoc'h M; Papoudou-Bai A; Kanavaros P
    Pathol Res Pract; 2022 Aug; 236():153964. PubMed ID: 35700577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
    Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
    Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
    Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
    Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatment.
    Birkenmeier K; Moll K; Newrzela S; Hartmann S; Dröse S; Hansmann ML
    Oncotarget; 2016 Jul; 7(29):46579-46588. PubMed ID: 27366944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    Rengstl B; Kim S; Döring C; Weiser C; Bein J; Bankov K; Herling M; Newrzela S; Hansmann ML; Hartmann S
    PLoS One; 2017; 12(5):e0177378. PubMed ID: 28505189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
    Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
    PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
    Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
    Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin lymphoma: Pathology and biology.
    Mathas S; Hartmann S; Küppers R
    Semin Hematol; 2016 Jul; 53(3):139-47. PubMed ID: 27496304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
    Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
    APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD47 antigen in Reed-Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma.
    López-Pereira B; Fernández-Velasco AA; Fernández-Vega I; Corte-Torres D; Quirós C; Villegas JA; Palomo P; González S; González AP; Payer Á; Bernal T; Moro-García MA; Alonso-Arias R; Alonso-Álvarez S; Colado E
    Clin Transl Oncol; 2020 May; 22(5):782-785. PubMed ID: 31359339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    Janz M; Hummel M; Truss M; Wollert-Wulf B; Mathas S; Jöhrens K; Hagemeier C; Bommert K; Stein H; Dörken B; Bargou RC
    Blood; 2006 Mar; 107(6):2536-9. PubMed ID: 16263788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Senescence Markers p16INK4a and p21CIP1/WAF Are Predictors of Hodgkin Lymphoma Outcome.
    Caliò A; Zamò A; Ponzoni M; Zanolin ME; Ferreri AJ; Pedron S; Montagna L; Parolini C; Fraifeld VE; Wolfson M; Yanai H; Pizzolo G; Doglioni C; Vinante F; Chilosi M
    Clin Cancer Res; 2015 Nov; 21(22):5164-72. PubMed ID: 26199387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation.
    Birkenmeier K; Dröse S; Wittig I; Winkelmann R; Käfer V; Döring C; Hartmann S; Wenz T; Reichert AS; Brandt U; Hansmann ML
    Int J Cancer; 2016 May; 138(9):2231-46. PubMed ID: 26595876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
    Barth TF; Martin-Subero JI; Joos S; Menz CK; Hasel C; Mechtersheimer G; Parwaresch RM; Lichter P; Siebert R; Möoller P
    Blood; 2003 May; 101(9):3681-6. PubMed ID: 12511414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.